LEADER 01559nam  2200385Ia 450 
001 9910698911803321
005 20090723143415.0
035   $a(CKB)5470000002398762
035   $a(OCoLC)427562611
035   $a(EXLCZ)995470000002398762
100   $a20090723d1998      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aInformation sheet$b[electronic resource] $eguidance for institutional review boards and clinical investigators (use of investigational products when subjects enter a second institution)
210  1$a[Rockville, MD] :$c[U.S. Dept. of Health and Human Services, Food and Drug Administration],$d[1998?]
215   $a1 electronic text $cHTML file
300   $aTitle from HTML caption (viewed on July 23, 2009).
300   $a"01/1998"--Title index listing.
517   $aInformation sheet 
606   $aMedicine, Experimental$xGovernment policy$zUnited States
606   $aInstitutional review boards (Medicine)$xGovernment policy$zUnited States
606   $aMedical research personnel$xGovernment policy$zUnited States
615  0$aMedicine, Experimental$xGovernment policy
615  0$aInstitutional review boards (Medicine)$xGovernment policy
615  0$aMedical research personnel$xGovernment policy
712 02$aUnited States.$bFood and Drug Administration.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910698911803321
996   $aInformation sheet$93444655
997   $aUNINA